[1] Ruiz P, Günthert U. The cellular basis of metastasis [J]. World J Urol, 1996, 14(3): 141 [2] Liotta L A, Kohn E C. The microenvironment of the tumour-host interface [J]. Nature, 2001, 411(6835): 375 [3] Egeblad M, Littlepage L E, Werb Z. The fibroblastic coconspirator in cancer progression [J]. Cold Spring Harb Symp Quant Biol, 2005, 70: 383 [4] Stanisavljevic J, Loubat-Casanovas J, Herrera M, et al. Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasis [J]. Cancer Res, 2015, 75(2): 284 [5] Shimoda M, Principe S, Jackson H W, et al. Loss of the Timp gene family is sufficient for the acquisition of the CAF-like cell state[J]. Nat Cell Biol, 2014, 16(9): 889 [6] Paland N, Kamer I, Kogan-Sakin I, et al. Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer[J]. Mol Cancer Res, 2009, 7(8): 1212 [7] Wu M H, Hong H C, Hong T M, et al. Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1/CCL2 expression[J]. Clin Cancer Res, 2011, 17(6): 1306 [8] Zhang Y, Tang H, Cai J, et al. Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion[J]. Cancer Lett, 2011, 303(1): 47 [9] Cui L, Ohuchida K, Mizumoto K, et al. Prospectively isolated cancer-associated CD10(+) fibroblasts have stronger interactions with CD133(+) colon cancer cells than with CD133(-) cancer cells [J]. PLoS One, 2010, 5(8): e12121 [10] Ikenaga N, Ohuchida K, Mizumoto K, et al. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer [J]. Gastroenterology, 2010, 139(3): 1041 [11] Henriksson M L, Edin S, Dahlin A M, et al. Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion [J]. Am J Pathol, 2011, 178(3): 1387 [12] Lee K W, Yeo S Y, Sung C O, et al. Twist1 is a key regulator of cancer-associated fibroblasts [J]. Cancer Res, 2015, 75(1): 73 [13] Lu J, Ye X, Fan F, et al. Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1[J]. Cancer Cell, 2013, 23(2): 171 [14] Ding X Y, Ding J, Wu K, et al. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth[J]. Oncogene, 2012, 31(23): 2899 [15] Galan-Moya E M, Le Guelte A, Lima Fernandes E, et al. Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway[J]. EMBO Rep, 2011, 12(5): 470 [16] Ricci-Vitiani L, Pallini R, Biffoni M, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells[J]. Nature, 2010, 468(7325): 824 [17] Wang R, Chadalavada K, Wilshire J, et al. Glioblastoma stem-like cells give rise to tumour endothelium [J]. Nature, 2010, 468(7325): 829 [18] Radke I,Gotte M, Kersting C, et al. Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer [J]. Br J Cancer, 2006, 95(3): 347 [19] Mi Z, Bhattacharya S D, Kim V, et al. Osteopontin promotes CCL5-mesenchymal stromal cell mediated breast cancer metastasis[J]. Carcinogenesis, 2011, 32(4): 477 [20] Karnoub A E, Dash A B, Vo A P, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis [J]. Nature, 2007, 449(7162): 557 [21] Peng Y, Li Z, Yang P , et al. Direct contacts with colon cancer cells regulate the differentiation of bone marrow mesenchymal stem cells into tumor associated fibroblasts [J]. Biochem Biophys Res Commun, 2014, 451(1): 68 [22] Borsi E, Perrone G, Terragna C, et al. HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment[J]. Exp Cell Res, 2014, 328(2): 444 [23] Nakagaki S, Arimura Y, Nagaishi K, et al. Contextual niche signals towards colorectal tumor progression by mesenchymal stem cell in the mouse xenograft model [J]. J Gastroenterol, 2015, [Epub ahead of print] [24] Ramasamy R, Lam E W, Soeiro I, et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth [J]. Leukemia, 2007, 21(2): 304 [25] Khakoo A Y, Pati S, Anderson S A, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi’s sarcoma [J]. J Exp Med, 2006, 203(5): 1235 [26] Sun B, Roh K H, Park J R, et al. Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model [J]. Cytotherapy, 2009, 11(3): 289-298 [27] Menck K, Klemm F, et al. Induction and transport of Wnt5a during macrophage-induced malignant invasion is mediated by two types of extracellular vesicles. Oncotarget, 2013, 4(11): 2057-2066 [28] Rao G, Wang H, Li B, et al. Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer [J]. Clin Cancer Res, 2013, 19(4): 785 [29] Su S, Liu Q, Chen J, et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis [J]. Cancer Cell, 2014, 25(5): 605 [30] Chen J, Yao Y, Gong C, et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3[J]. Cancer Cell, 2011, 19(4): 541 [31] D’Esposito V, Passaretti F, Hammarstedt A, et al. Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro[J]. Diabetologia, 2012, 55(10): 2811 [32] Nieman K M, Kenny H A, Penicka C V, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapaid tumor growth[J]. Nat Med, 2011, 17(11): 1498 [33] Fujisaki K, Fujimoto H, Sangai T, et al. Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1[J]. Breast Cancer Res Treat, 2015, 150(2): 255 [34] Onuma M, Bub J D, Rummel T L, Iwamoto Y. Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase[J]. J Biol Chem, 2003, 278(43): 42660 [35] Baessler T, Krusch M, Schmiedel B J, et al. Glucocorticoid-induced tumor necrosis factor receptor-related protein ligand subverts immunosurveillance of acute myeloid leukemia in humans[J]. Cancer Res, 2009, 69(3): 1037 [36] Ribatti D, Crivellato E, Roccaro A M , et al. Mast cell contribution to angiogenesis related to tumour progression[J]. Clin Exp Allergy, 2004, 34(11): 1660
[1]孙冉,习贵富,赵楠,等.结直肠癌中PAQR3的表达水平及临床病理意义[J].天津医科大学学报,2023,29(06):582.
SUN Ran,XI Gui-fu,ZHAO Nan,et al.The expression level and clinicopathologic significance of PAQR3 in colorectal cancer[J].Journal of Tianjin Medical University,2023,29(05):582.
[2]王宇,刘超 综述,周旋 审校.PAI-1在肿瘤进展中的功能与机制探讨[J].天津医科大学学报,2024,30(01):96.[doi:10.20135/j.issn.1006-8147.2024.01.0096]